Clinical outcomes of locally advanced esophageal neuroendocrine carcinoma treated with chemoradiotherapy

BACKGROUND: Neuroendocrine carcinoma (NEC) arising from the esophagus (EsoNEC) is extreme rare, accounting for approximately 1% of esophageal cancer. Even for localized NEC, multidisciplinary approach including chemotherapy is recommended in treatment guidelines because of its high rates of systemic...

Descripción completa

Detalles Bibliográficos
Autores principales: Honma, Yoshitaka, Nagashima, Kengo, Hirano, Hidekazu, Shoji, Hirokazu, Iwasa, Satoru, Takashima, Atsuo, Okita, Natsuko, Kato, Ken, Boku, Narikazu, Murakami, Naoya, Inaba, Kouji, Ito, Yoshinori, Itami, Jun, Kanamori, Jun, Oguma, Junya, Daiko, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970034/
https://www.ncbi.nlm.nih.gov/pubmed/31794158
http://dx.doi.org/10.1002/cam4.2708

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6970034/
https://www.ncbi.nlm.nih.gov/pubmed/31794158
http://dx.doi.org/10.1002/cam4.2708

Ejemplares similares